Molecular Docking and Dynamic Simulation Revealed the Potential Inhibitory Activity of Opioid Compounds Targeting the Main Protease of SARS-CoV-2

<div>2D and 3D binding modes of ligand interacted with the M<sup>pro</sup> active site (PDB ID 6LU7).</div>

BioMed Research International

fig4

Figure 4

Figure 4: Molecular Docking and Dynamic Simulation Revealed the Potential Inhibitory Activity of Opioid Compounds Targeting the Main Protease of SARS-CoV-2 

Figure 4 | Molecular Docking and Dynamic Simulation Revealed the Potential Inhibitory Activity of Opioid Compounds Targeting the Main Protease of SARS-CoV-2 